Jean-Pierre Gerber

Gestore di Portafoglio-Azioni presso Bellevue Asset Management AG

Finance

Profilo

Mr. Jean-Pierre Gerber is a Product Specialist at Bellevue Asset Management AG.
He formerly worked as Head of Fund Research and Equity Product Specialist for Julius Baer Asset Management, and as a Business Audit and Consulting Associate for Ernst & Young.
Mr. Gerber holds a Master's degree in Business Economics, following studies at the University of Berne and the University of Warwick, UK.

Posizioni attive di Jean-Pierre Gerber

Società	Posizione	Inizio
Bellevue Asset Management AG Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.	Gestore di Portafoglio-Azioni	01/01/2009

Tutte le posizioni attive di Jean-Pierre Gerber

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jean-Pierre Gerber

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Bellevue Asset Management AG Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.	Finance